22 Results for "

autoantibodies

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "autoantibodies" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P2171A
Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

CCP peptide TFA is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide TFA functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-147305
CAS No.: 1821402-21-4
Synonyms: ARGX-113
Efgartigimod alfa (ARGX-113) is a reversibility, humanized Fc receptor antagonist . Efgartigimod alfa is a anti FcRn monoclonal immunoglobulin G (IgG1) Fc fragment. Efgartigimod reduces serum levels of total IgG, including pathogenic autoantibodies, by blocking FcRn function without permanent impairment. Efgartigimod alfa can be used for generalised myasthenia gravis (gMG) and primary immune thrombocytopenia research .
loading...
    loading...
Cat. No.: HY-P990706
CAS No.: 2490217-42-8
Synonyms: ALPN-303

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Povetacicept (ALPN-303) is an engineered Fc fusion protein containing the TACI domain, and acts as a dual APRIL/BAFF antagonist. The Kd value of Povetacicept for human BAFF is 59.3 pM, while its Kd value for human APRIL is 1.00 pM. Povetacicept reduces the activation, proliferation, differentiation and survival of B cells, and inhibits the production of immunoglobulins and autoantibodies. Povetacicept can be used in research related to autoimmune hemolytic anemia, immune thrombocytopenia, systemic lupus erythematosus, lupus nephritis and myasthenia gravis .
loading...
    loading...
Cat. No.: HY-148826
CAS No.: 145563-68-4
Synonyms: ARC 183; BC 007
Rovunaptabin (ARC 183) is an aptamer, a single-stranded DNA molecule composed of 15 deoxynucleotides. It acts as a broad-spectrum neutralizer of pathogenic G-protein-coupled receptor autoantibodies. Rovunaptabin can be used in research related to cardiomyopathy and pulmonary hypertension .
loading...
    loading...
Cat. No.: HY-P5912
Target:  

iGluR Calcium Channel

Research Areas:  

Neurological Disease

GluN1 (356-385) is a polypeptide targeting NMDAR GluN1. GluN1 (356-385) induces the production of autoantibodies, which reduce the density of cell surface NMDAR clusters, impair long-term potentiation, and decrease NMDAR-mediated Ca 2+ influx. As an immunogen, GluN1 (356-385) induces symptoms similar to anti-NMDAR encephalitis, including memory loss, in mice. GluN1 (356-385) can be used to establish a mouse model that mimics the pathogenesis of anti-NMDAR encephalitis. GluN1 (356-385) is applicable to research related to anti-NMDAR encephalitis .
loading...
    loading...
Cat. No.: HY-P991400
GSK1995057 is a human monoclonal antibody (mAb) targeting TNFRSF1A. GSK1995057 selectively binds to TNFR1, blocks the binding of TNF-α and LT-α, and does not interfere with TNFR2 signaling. GSK1995057 inhibits the activation of NF-κB, JNK and MAPK pathways, alleviates apoptosis (apoptosis) and inflammatory responses (inhibiting IL-1β, IL-6, IL-10, TNF-α), and prevents viability loss of human nucleus pulposus cells. GSK1995057 inhibits the expression of cytokines and neutrophil adhesion molecules in human pulmonary microvascular endothelial cell monolayers, and reduces inflammatory responses and lung injury symptoms in non-human primates. GSK1995057 forms complexes with HAVH autoantibodies, thereby activating TNFR1 and triggering the release of cytokines and IL-8 in human cells. GSK1995057 can be used in research related to intervertebral disc degeneration and acute lung injury .
loading...
    loading...
Cat. No.: HY-W007346
CAS No.: 591-31-1
Synonyms: 3-Methoxybenzaldehyde
m-Anisaldehyde (3-Methoxybenzaldehyde) is an aromatic aldehyde that exhibits low fumigant insecticidal activity against Lycoriella ingenua larvae. m-Anisaldehyde is a characteristic serum metabolite that is negatively correlated with uric acid in late pregnancy and negatively correlated with thyroid autoantibodies TPOAb and TgAb. m-Anisaldehyde can be used in studies of thyroid autoimmunity .
loading...
    loading...
Cat. No.: HY-P991611
CAS No.: 3058434-76-4

Target:  

iGluR

Research Areas:  

Inflammation/Immunology

ART5803 is a humanized IgG1 monoclonal antibody inhibitor targeting NMDAR. ART5803 binds to the N-terminal domain (NTD) of the NMDAR GluN1 subunit (GluN1-NTD) with a high affinity. ART5803 blocks NMDAR internalization induced by pathogenic autoantibodies and restores cell-surface NMDAR expression and functions. ART5803 reverses behavioral abnormalities and NMDAR expression in marmoset disease models. ABT-147 can be used to study anti-NMDAR encephalitis .
loading...
    loading...
Cat. No.: HY-P2171
CAS No.: 277748-59-1
Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

CCP peptide is a synthetic cyclic citrullinated peptide (CCP) and used as the substrate for detecting anti-CCP antibodies serologically. CCP peptide functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-P99952
CAS No.: 2249927-04-4
Synonyms: SCT400
Ripertamab (SCT400) is a recombinant human-mouse chimeric anti-CD20 IgG1κ monoclonal antibody. As an immunomodulator, ripertamab reduces the levels of pathogenic autoantibodies, alleviates immune complex deposition, and blocks the antigen-presenting function of cells. Ripertamab depletes CD20-positive cells. Ripertamab can induce infusion-related reactions, pulmonary toxicity, neutropenia and thrombocytopenia. Ripertamab is applicable to research related to non-Hodgkin's lymphoma, primary membranous nephropathy and idiopathic membranous nephropathy .
loading...
    loading...
Cat. No.: HY-169853
CAS No.: 1189495-81-5
M351-0056 is an orally active VISTA agonist with a Kd value of 12.60 μM. M351-0056 inhibits the activation of the JAK2-STAT2 pathway, reduces the phosphorylation levels of JAK2 and STAT2, and regulates type I interferon (IFN-I) and non-canonical NF-κB pathways. M351-0056 decreases the levels of cytokines (IFN-γ, IL-17A, TNF-α, IL-2 and IL-1β). M351-0056 improves imiquimod (HY-B0180)-induced psoriasis-like skin inflammation, reduces autoantibody levels, kidney damage and immune cell expansion in mice susceptible to chronic graft-versus-host disease and lupus, and delays the progression of systemic lupus erythematosus. M351-0056 can be used in research related to psoriasis-like dermatitis and systemic lupus erythematosus .
loading...
    loading...
Cat. No.: HY-148412
CAS No.: 864021-55-6
Synonyms: EN101; ODN 7040; BL 7040
Target:  

Cholinesterase (ChE)

Research Areas:  

Others

Monarsen (EN101) is a synthetic 20-base antisense oligodeoxynucleotide directed against the human AChE gene. Monarsen is used in the study of Autoimmune myasthenia gravis (MG), a neuromuscular disorder caused by autoantibodies directed against the acetylcholine receptor (AChR).
loading...
    loading...
Cat. No.: HY-117573
CAS No.: 1438280-73-9
1Z105 is an orally active TLR4/MD2 agonist, immunostimulant and vaccine adjuvant. 1Z105 activates NF-κB via the MyD88/TRIF pathway in a CD14-independent manner, with EC50 values of 0.63 µM and 0.77 µM for inducing IL-6 and IL-12 in mBMDCs, respectively. 1Z105 promotes dendritic cell maturation, antigen uptake and cross-presentation; when used alone, it induces Th2-IgG1, while combined with the TLR7 agonist 1V270, it synergistically induces balanced Th1/Th2 responses and provides low-reactogenic protection against homologous, heterologous and heterosubtypic influenza. 1Z105 prevents LPS (HY-D1056A1)- and galactosamine-induced liver injury as well as autoantibody-driven arthritis in mice. 1Z105 can be used in studies related to influenza virus infection, inflammation, and LPS/galactosamine-induced liver injury .
loading...
    loading...
Cat. No.: HY-148412A
Synonyms: EN101 sodium; ODN 7040 sodium; BL 7040 sodium
Target:  

Cholinesterase (ChE)

Research Areas:  

Others

Monarsen sodium is a synthetic 20-base antisense oligodeoxynucleotide directed against the human AChE gene. Monarsen sodium is used in the study of Autoimmune myasthenia gravis (MG), a neuromuscular disorder caused by autoantibodies directed against the acetylcholine receptor (AChR).
loading...
    loading...
Cat. No.: HY-P10597
CAS No.: 275359-37-0
Target:  

Angiotensin Receptor

Research Areas:  

Others

Angiotensin II type 1 receptor (181-187) is a 9-amino acid sequence of the second extracellular loop of angiotensin II (Ang II) in the renin-angiotensin system. Angiotensin II type 1 receptor (181-187) serves as the localization epitope of angiotensin II receptor autoantibodies (AT1RaAb) and is used to detect and quantify AT1RaAb levels in serum .
loading...
    loading...
Cat. No.: HY-W007346R
CAS No.: 591-31-1
Synonyms: 3-Methoxybenzaldehyde (Standard)
m-Anisaldehyde (Standard) (3-Methoxybenzaldehyde (Standard)) is the analytical standard of m-Anisaldehyde (HY-W007346). This product is intended for research and analytical applications. m-Anisaldehyde (3-Methoxybenzaldehyde) is an aromatic aldehyde that exhibits low fumigant insecticidal activity against Lycoriella ingenua larvae. m-Anisaldehyde is a characteristic serum metabolite that is negatively correlated with uric acid in late pregnancy and negatively correlated with thyroid autoantibodies TPOAb and TgAb. m-Anisaldehyde can be used in studies of thyroid autoimmunity .
loading...
    loading...
Cat. No.: HY-W007346S
CAS No.: 1219795-07-9
m-Anisaldehyde-d3 is the deuterated-labeled m-Anisaldehyde (HY-W007346). m-Anisaldehyde (3-Methoxybenzaldehyde) is an aromatic aldehyde that exhibits low fumigant insecticidal activity against Lycoriella ingenua larvae. m-Anisaldehyde is a characteristic serum metabolite that is negatively correlated with uric acid in late pregnancy and negatively correlated with thyroid autoantibodies TPOAb and TgAb. m-Anisaldehyde can be used in studies of thyroid autoimmunity .
loading...
    loading...
Cat. No.: HY-180323
CAS No.: 196517-43-8
Target:  

RAR/RXR

Research Areas:  

Inflammation/Immunology

ER-38925 is a retinoid agonist with selevtivity to retinoic acid receptor subtype α (RAR-α). ER-38925 prolongs the lifespan of the recipient mice dose-dependently. ER-38925 potently inhibits alloantigenstimulated donor T lymphocyte prolifertion in vitro. ER-38925 can prevent the development of antiallogeneic cytotoxic T lymphocyte response in mice. ER-38925 inhibits serum anti-DNA autoantibody production in mouse model of human chronic GVHD .
loading...
    loading...
Cat. No.: HY-P992101
CAS No.: 3057276-00-0
Synonyms: AUR-200
Aritinercept (AUR-200) is a recombinant fusion protein targeting TNFSF13B/BAFF/CD257. Aritinercept neutralizes BAFF and APRIL (TNFSF13), reduces B cell proliferation, suppresses peripheral B cells, lowers serum immunoglobulins. Aritinercept reduces renal damage markers, decreases IFNγ, IL-17A, and anti-dsDNA autoantibodies, and improves survival in a mouse model of SLE. ritinercept can be used for the research of systemic lupus erythematosus .
loading...
    loading...
Cat. No.: HY-P11796
CAS No.: 1235835-17-2
Research Areas:  

Inflammation/Immunology

MOG 37-46 is a dominant immunodominant CD8 + T cell epitope. As a truncated version of MOG35-55, MOG 37-46 is recognizable by MOG 35-55-specific T cells, and serves as an autoantibody target at the dimer interface of the extracellular domain of myelin oligodendrocyte glycoprotein (MOG). MOG 37-46 stimulates MOG-specific CD8 + T cell lines and proinflammatory CD8 + T cells migrating into the central nervous system (CNS) to produce IFN-γ. MOG 37-46 is applicable to research related to experimental autoimmune encephalomyelitis .
loading...
    loading...